Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H D Preisler

Showing results (81-90 of 271) with videos related to

Pageof 28
Sort By:
American Journal of Hematology|January 1, 1980
Another look at survival curves in chronic myelocytic leukemiaH D Preisler, P A Reese
Journal of the National Cancer Institute|November 1, 1971
Effect of cytosine arabinoside and 1,3-bis(2-chloroethyl)-1-nitrosourea on hematopoietic precursors in the mouseH D Preisler, E S Henderson
Cytometry|November 1, 1985
Double labeling and in vitro versus in vivo incorporation of bromodeoxyuridine in patients with acute nonlymphocytic leukemiaA Raza, K Ucar, H D Preisler
Medical and Pediatric Oncology|January 1, 1981
Prevention of infection and bleeding in leukemic patients receiving intensive remission maintenance therapyH D Preisler, A Early, W Hryniuk
Blood|June 1, 1987
Differences in cell cycle characteristics among patients with acute nonlymphocytic leukemiaA Raza, Y Maheshwari, H D Preisler
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|May 1, 1987
Immunoperoxidase detection of myeloid antigens in glycolmethacrylate-embedded human bone marrowE Archimbaud, A Islam, H D Preisler
Stain Technology|March 1, 1986
Alcian blue method for attaching glycol methacrylate bone marrow sections to glass slidesE Archimbaud, A Islam, H D Preisler
Blood|March 1, 1976
Cryoprotective agents as inducers of erythroleukemic cell differentiation in vitroH D Preisler, G Christoff, E Taylor
American Journal of Hematology|February 1, 1985
Lack of relationship between in vitro cell measurements and response to busulfan in chronic myelocytic leukemiaJ Kirshner, H D Preisler, A Raza
Leukemia & Lymphoma|January 1, 1993
Proliferative advantage rather than classical drug resistance as the cause of treatment failure in chronic myelogenous leukemiaH D Preisler, A Raza, M Baccarani
Pageof 28

Showing results (81-90 of 271) with videos related to

Sort By:
Pageof 28
American Journal of Hematology|January 1, 1980
Another look at survival curves in chronic myelocytic leukemiaH D Preisler, P A Reese
Journal of the National Cancer Institute|November 1, 1971
Effect of cytosine arabinoside and 1,3-bis(2-chloroethyl)-1-nitrosourea on hematopoietic precursors in the mouseH D Preisler, E S Henderson
Cytometry|November 1, 1985
Double labeling and in vitro versus in vivo incorporation of bromodeoxyuridine in patients with acute nonlymphocytic leukemiaA Raza, K Ucar, H D Preisler
Medical and Pediatric Oncology|January 1, 1981
Prevention of infection and bleeding in leukemic patients receiving intensive remission maintenance therapyH D Preisler, A Early, W Hryniuk
Blood|June 1, 1987
Differences in cell cycle characteristics among patients with acute nonlymphocytic leukemiaA Raza, Y Maheshwari, H D Preisler
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|May 1, 1987
Immunoperoxidase detection of myeloid antigens in glycolmethacrylate-embedded human bone marrowE Archimbaud, A Islam, H D Preisler
Stain Technology|March 1, 1986
Alcian blue method for attaching glycol methacrylate bone marrow sections to glass slidesE Archimbaud, A Islam, H D Preisler
Blood|March 1, 1976
Cryoprotective agents as inducers of erythroleukemic cell differentiation in vitroH D Preisler, G Christoff, E Taylor
American Journal of Hematology|February 1, 1985
Lack of relationship between in vitro cell measurements and response to busulfan in chronic myelocytic leukemiaJ Kirshner, H D Preisler, A Raza
Leukemia & Lymphoma|January 1, 1993
Proliferative advantage rather than classical drug resistance as the cause of treatment failure in chronic myelogenous leukemiaH D Preisler, A Raza, M Baccarani
Pageof 28